Search hospitals > Ontario > LONDON
London Health Sciences Centre - University Hospital
Claim this profileLONDON, Ontario N6A 5A5
Global Leader in Ulcerative Colitis
Global Leader in Colitis
Conducts research for Oral Ulcers
Conducts research for Crohn's Disease
Conducts research for Osteoarthritis
184 reported clinical trials
10 medical researchers
Summary
London Health Sciences Centre - University Hospital is a medical facility located in LONDON, Ontario. This center is recognized for care of Ulcerative Colitis, Colitis, Oral Ulcers, Crohn's Disease, Osteoarthritis and other specialties. London Health Sciences Centre - University Hospital is involved with conducting 184 clinical trials across 234 conditions. There are 10 research doctors associated with this hospital, such as Michael Chu, MD, Vipul Jairath, James Howard, MD, and Marko Mrkobrada, MD.Top PIs
Michael Chu, MDLondon Health Sciences Centre3 years of reported clinical research
Studies Coronary Artery Disease
Studies Stroke
17 reported clinical trials
26 drugs studied
Vipul JairathLondon Health Sciences Centre1 year of reported clinical research
Studies Crohn's Disease
Studies Ulcerative Colitis
14 reported clinical trials
14 drugs studied
James Howard, MDLondon Health Sciences Centre7 years of reported clinical research
Studies Osteoarthritis
Studies Hip Osteoarthritis
7 reported clinical trials
16 drugs studied
Marko Mrkobrada, MDLondon Health Sciences Centre - University Hospital4 years of reported clinical research
Studies Atrial Fibrillation
Studies Coronavirus
4 reported clinical trials
8 drugs studied
Clinical Trials running at London Health Sciences Centre - University Hospital
Colitis
Crohn's Disease
Heart Failure
Atrial Fibrillation
Oral Ulcers
Ulcerative Colitis
Post-Traumatic Stress Disorder
Osteoarthritis
Coronavirus
Stroke
Mirikizumab
for Ulcerative Colitis
This trial is testing mirikizumab, a medication for people with severe ulcerative colitis. It aims to see if the drug can reduce gut inflammation by blocking a protein that causes it. The study will last several years. Mirikizumab has shown positive results in early tests for ulcerative colitis.
Recruiting2 awards Phase 31 criteria
MK-7240
for Ulcerative Colitis
This trial is testing tulisokibart, a new medication, to see if it can help people with moderately to severely active ulcerative colitis. The goal is to determine if tulisokibart can reduce inflammation and heal sores in the colon, leading to fewer symptoms. The study will compare different doses of tulisokibart over several months.
Recruiting1 award Phase 3
TAK-279
for Ulcerative Colitis
The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The participants will take capsules of either TAK-279 or placebo for up to 3 months (12 weeks). Then all the participants will receive TAK-279 for the rest of the treatment part of the study (1 year or 52 weeks). During the study, participants will visit their study clinic several times.
Recruiting0 awards Phase 21 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at London Health Sciences Centre - University Hospital?
London Health Sciences Centre - University Hospital is a medical facility located in LONDON, Ontario. This center is recognized for care of Ulcerative Colitis, Colitis, Oral Ulcers, Crohn's Disease, Osteoarthritis and other specialties. London Health Sciences Centre - University Hospital is involved with conducting 184 clinical trials across 234 conditions. There are 10 research doctors associated with this hospital, such as Michael Chu, MD, Vipul Jairath, James Howard, MD, and Marko Mrkobrada, MD.